tradingkey.logo
๎™

Vivos Therapeutics Inc

VVOS
2.430USD
+0.070+2.97%
์ข…๊ฐ€ย 11/05, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
17.80M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

Vivos Therapeutics Inc

2.430
+0.070+2.97%
TradingKey ์ฃผ์‹ ์ ์ˆ˜
๊ฑด๊ฐ•
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
์œ ์‚ฌ ์ข…๋ชฉ
TradingKey ์ฃผ์‹ ์ ์ˆ˜
๊ฑด๊ฐ•
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
์œ ์‚ฌ ์ข…๋ชฉ

TradingKey Vivos Therapeutics Inc ์ฃผ์‹ ์ ์ˆ˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

ํšŒ์‚ฌ์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ์•ˆ์ •์ ํ•œ ํŽธ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ์œผ๋กœ ๊ฐ„์ฃผ๋ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€์˜ ์ธ์ง€๋„๋Š” ๋งค์šฐ ๋†’์€์ž…๋‹ˆ๋‹ค. ์ง€๋‚œ 30์ผ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๋“ค์ด ์ด ํšŒ์‚ฌ๋ฅผ ๋งค์ˆ˜๋กœ ํ‰๊ฐ€ํ–ˆ์Šต๋‹ˆ๋‹ค. ํšŒ์‚ฌ๋Š” ๋งค์šฐ ๋ถ€์ง„ํ•œ ์ฃผ์‹์‹œ์žฅ ์„ฑ๊ณผ๋ฅผ ๋ณด์ด๊ณ  ์žˆ์œผ๋ฉฐ, ์ด๋Š” ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ์™€๋„ ์ผ์น˜ํ•ฉ๋‹ˆ๋‹ค. ์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
138 / 210
์ „์ฒด ์ˆœ์œ„
329 / 4616
์‚ฐ์—…
์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๋ฐ์ดํ„ฐ ์—†์Œ

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

2 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
5.250
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+112.55%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

Vivos Therapeutics Inc ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
์„ฑ์žฅ ์ค‘
ํšŒ์‚ฌ๋Š” ์„ฑ์žฅ ๋‹จ๊ณ„์— ์žˆ์œผ๋ฉฐ, ์ตœ์‹  ์—ฐ๊ฐ„ ์ˆ˜์ต์€ ๋ฏธํ™” 15.03M์— ๋‹ฌํ•ฉ๋‹ˆ๋‹ค.
๊ณผ์†Œ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ -2.02๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋‚ฎ์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค๋„
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 766.93K์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 8.43% ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
CI Select Canadian Equity Fund๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž CI Select Canadian Equity Fund์ด(๊ฐ€) ์ด ์ฃผ์‹ 547.00์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์žฌ๋ฌด ๊ฑด์ „์„ฑ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์žฌ๋ฌด ์ ์ˆ˜๋Š” 5.49์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์—…๊ณ„ ํ‰๊ท ์ธ 7.46๋ณด๋‹ค ๋ฏธ๋งŒ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ์žฌ๋ฌด ์ƒํƒœ๋Š” ์•ฝํ•œ์ž…๋‹ˆ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ํšŒ์‚ฌ์˜ ์šด์˜ ํšจ์œจ์„ฑ์€ ํ•˜๋‹จ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ์ตœ์‹  ๋ถ„๊ธฐ ๋งค์ถœ์€ 3.82M๋ฅผ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ์ด๋Š” ์ „๋…„ ๋Œ€๋น„ 5.77%์˜ ๊ฐ์†Œ๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ํ•œํŽธ, ์ˆœ์ด์ต์€ ์ „๋…„ ๋Œ€๋น„ 159.74%์˜ ๊ฐ์†Œ๋ฅผ ๋ณด์˜€์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
5.49
๋ณ€๊ฒฝ
0
๎™ธ

์žฌ๋ฌด ์ •๋ณด

๎˜ญ5.64

๊ด€๋ จ ์ง€ํ‘œ

ํ˜„๊ธˆ ๋ฐ ํ˜„๊ธˆ์„ฑ ์ž์‚ฐ
์ด ์ž์‚ฐ
๋ถ€์ฑ„ ์ด๊ณ„
์ž์œ  ํ˜„๊ธˆ ํ๋ฆ„
๋ฐ์ดํ„ฐ ์—†์Œ
๎™น

์ˆ˜์ต์˜ ์งˆ

๎˜ญ6.59
๎™น

์šด์˜ ํšจ์œจ์„ฑ

๎˜ญ2.57
๎™น

์„ฑ์žฅ ์ž ์žฌ๋ ฅ

๎˜ญ5.56
๎™น

์ฃผ์ฃผ ์ˆ˜์ต๋ฅ 

๎˜ญ7.10

Vivos Therapeutics Inc ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๋ฐธ๋ฅ˜์—์ด์…˜ ์ ์ˆ˜๋Š” 8.23์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์—…๊ณ„ ํ‰๊ท ์ธ 7.19๋ณด๋‹ค ์ด์ƒ์ž…๋‹ˆ๋‹ค. ํ˜„์žฌ ์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ(P/E)์€ -2.02๋กœ, ์ตœ๊ทผ ๊ณ ์  -0.14 ๋Œ€๋น„ -92.90% ๋‚ฎ๊ณ , ์ตœ๊ทผ ์ €์  -5.96 ๋Œ€๋น„ -194.48% ๋†’์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
8.23
๋ณ€๊ฒฝ
0

๋ฐธ๋ฅ˜์—์ด์…˜

์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
P/B
์ฃผ๊ฐ€๋งค์ถœ๋น„์œจ
์ฃผ๊ฐ€ํ˜„๊ธˆํ๋ฆ„๋น„์œจ
์‚ฐ์—… ์ˆœ์œ„ 138/210
๋ฐ์ดํ„ฐ ์—†์Œ

์˜ˆ์ƒ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์‹ค์  ์ „๋ง ์ ์ˆ˜๋Š” 7.00์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์—…๊ณ„ ํ‰๊ท ์ธ 7.74๋ณด๋‹ค ๋ฏธ๋งŒ์ž…๋‹ˆ๋‹ค. Vivos Therapeutics Inc์˜ ํ‰๊ท  ๋ชฉํ‘œ๊ฐ€๋Š” 5.25์ด๋ฉฐ, ์ตœ๊ณ ๊ฐ€๋Š” 6.50, ์ตœ์ €๊ฐ€๋Š” 4.00์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
7.00
๋ณ€๊ฒฝ
0

๋ชฉํ‘œ๊ฐ€

๋ฐ์ดํ„ฐ ์—†์Œ

์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€

2 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
5.250
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+122.46%
์ƒ์Šน ์—ฌ๋ ฅ
๊ฐ•๋ ฅ ๋งค์ˆ˜
๋งค์ˆ˜
์œ ์ง€
๋งค๋„
๊ฐ•๋ ฅ ๋งค๋„

๋™์ข…์—…๊ณ„ ๋น„๊ต

110
์ด๊ณ„
7
์ค‘๊ฐ„
9
ํ‰๊ท 
ํšŒ์‚ฌ ์ด๋ฆ„
ํ‰๊ฐ€
๋ถ„์„๊ฐ€
Vivos Therapeutics Inc
VVOS
2
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
32
Dexcom Inc
DXCM
30
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
22

์žฌ๋ฌด ์˜ˆ์ธก

EPS
์ˆ˜์ต
์ˆœ์ด์ต
EBIT
๋ฐ์ดํ„ฐ ์—†์Œ

๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

๋ชจ๋ฉ˜ํ…€๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

์ด ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์ฃผ๊ฐ€ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋Š” 4.79์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์—…์ข… ํ‰๊ท  6.77๋ณด๋‹ค ๋ฏธ๋งŒ์ž…๋‹ˆ๋‹ค. ํšก๋ณด: ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 2.98 ์ €ํ•ญ์„ ๊ณผ 2.05 ์ง€์ง€์„  ์‚ฌ์ด์—์„œ ๊ฑฐ๋ž˜๋˜๊ณ  ์žˆ์–ด, ๊ตฌ๊ฐ„ ๋งค๋งค(Swing Trading)์— ์ ํ•ฉํ•œ ํ๋ฆ„์„ ๋ณด์ด๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
4.69
๋ณ€๊ฒฝ
0.1

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๋ฐ์ดํ„ฐ ์—†์Œ

์ง€ํ‘œ

๎˜ฐ
๎˜ฐ

์ง€ํ‘œ ๊ธฐ๋Šฅ์€ ๋‹ค์–‘ํ•œ ๊ธฐ๋ฒ• ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ์—ฌ๋Ÿฌ ์ข…๋ชฉ์— ๋Œ€ํ•œ ๊ฐ€์น˜์™€ ๋ฐฉํ–ฅ ๋ถ„์„์„ ์ œ๊ณตํ•˜๋ฉฐ, ๊ธฐ์ˆ ์  ์š”์•ฝ๋„ ํ•จ๊ป˜ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

์ด ๊ธฐ๋Šฅ์—๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์‚ฌ์šฉ๋˜๋Š” 9๊ฐ€์ง€ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๊ฐ€ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX, MA. ๋˜ํ•œ ํ•„์š”์— ๋”ฐ๋ผ ์‹œ๊ฐ„ ํ”„๋ ˆ์ž„์„ ์กฐ์ •ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ธฐ์ˆ  ๋ถ„์„์€ ํˆฌ์ž ์ฐธ์กฐ์˜ ์ผ๋ถ€์ผ ๋ฟ์ด๋ฉฐ, ๋ฐฉํ–ฅ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด ์ˆซ์ž ๊ฐ’์„ ์‚ฌ์šฉํ•˜๋Š” ๋ฐ์—๋Š” ์ ˆ๋Œ€์ ์ธ ๊ธฐ์ค€์ด ์—†์Šต๋‹ˆ๋‹ค. ๊ฒฐ๊ณผ๋Š” ์ฐธ์กฐ์šฉ์ผ ๋ฟ์ด๋ฉฐ, ์ง€ํ‘œ ๊ณ„์‚ฐ ๋ฐ ์š”์•ฝ์˜ ์ •ํ™•์„ฑ์— ๋Œ€ํ•ด์„œ๋Š” ์ฑ…์ž„์ง€์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์ง€ํ‘œ
๋งค๋„(3)
์ค‘๋ฆฝ(1)
๋งค์ˆ˜(1)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
-0.032
๋งค๋„
RSI(14)
32.391
์ค‘๋ฆฝ
STOCH(KDJ)(9,3,3)
7.663
๊ณผ๋งค์ˆ˜
ATR(14)
0.213
๊ณ ๋ณ€๋™์„ฑ
CCI(14)
-118.626
๋งค๋„
Williams %R
89.404
๊ณผ๋งค์ˆ˜
TRIX(12,20)
-1.073
๋งค๋„
StochRSI(14)
71.035
๋งค์ˆ˜
์ด๋™ ํ‰๊ท 
๋งค๋„(6)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(0)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
2.484
๋งค๋„
MA10
2.639
๋งค๋„
MA20
2.810
๋งค๋„
MA50
3.296
๋งค๋„
MA100
3.938
๋งค๋„
MA200
3.492
๋งค๋„

๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๊ธฐ๊ด€ ์ธ์ง€๋„ ์ ์ˆ˜๋Š” 3.00์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์—…๊ณ„ ํ‰๊ท ์ธ 6.39๋ณด๋‹ค ๋ฏธ๋งŒ ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค. ์ตœ์‹  ๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ  ๋น„์œจ์€ 10.22%์ด๋ฉฐ, ์ด๋Š” ๋ถ„๊ธฐ ๋Œ€๋น„ ๊ฐ์†Œ 69.13%์ž…๋‹ˆ๋‹ค. ์ตœ๋Œ€ ๊ธฐ๊ด€ ์ฃผ์ฃผ๋Š” ๋” ๋ฑ…๊ฐ€๋“œ๋กœ, ์ด 42.63K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ ์ด๋Š” ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 0.57%์— ํ•ด๋‹นํ•ฉ๋‹ˆ๋‹ค. ๋ณด์œ  ์ง€๋ถ„์€ 216.31% ์ฆ๊ฐ€๋ฅผ ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
3.00
๋ณ€๊ฒฝ
0

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์ฃผ ํ™œ๋™

์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
Chg %
Skaff (Michael C.)
828.00K
--
Luo (Dawei)
572.02K
--
V-CO Investors, L.L.C.
514.50K
--
Armistice Capital LLC
250.28K
--
Intracoastal Capital, L.L.C.
228.61K
--
UBS Financial Services, Inc.
142.80K
+7499.84%
Ionic Ventures LLC
83.00K
--
Huntsman (Ronald Kirk)
73.06K
--
Geode Capital Management, L.L.C.
57.90K
+0.96%
Cutter & Company, Inc.
49.10K
+28.87%
1
2

์œ„ํ—˜ ์š”์†Œ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2025-11-04

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๋ฆฌ์Šคํฌ ํ‰๊ฐ€ ์ ์ˆ˜๋Š” 2.27์ด๋ฉฐ, ์ด๋Š” ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์‚ฐ์—… ํ‰๊ท ์ธ 4.57๋ณด๋‹ค ๋ฏธ๋งŒ ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ๋ฒ ํƒ€ ๊ฐ’์€ 6.84์ž…๋‹ˆ๋‹ค. ์ด๋Š” ํ•ด๋‹น ์ฃผ์‹์ด ์ƒ์Šน์žฅ์—์„œ๋Š” ์ง€์ˆ˜๋ฅผ ์ดˆ๊ณผํ•˜์—ฌ ์„ฑ๊ณผ๋ฅผ ๋‚ด๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์ง€๋งŒ, ํ•˜๋ฝ์žฅ์—์„œ๋Š” ์ง€์ˆ˜๋ณด๋‹ค ๋” ํฐ ํ•˜๋ฝ์„ ๊ฒช๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
2.27
๋ณ€๊ฒฝ
0
S&P 500 ์ง€์ˆ˜ ๋Œ€๋น„ ๋ฒ ํƒ€๊ฐ’
6.85
VaR
+10.17%
240์ผ ์ตœ๋Œ€ ๋‚™ํญ
+66.04%
240์ผ ๋ณ€๋™์„ฑ
+118.51%

๋Œ์•„๊ฐ€๊ธฐ

์ตœ๊ณ  ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
+11.38%
120์ผ
+22.47%
5๋…„
+833.94%
์ตœ์ € ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
-10.85%
120์ผ
-16.99%
5๋…„
-40.24%
์ƒคํ”„ ๋น„์œจ
60์ผ
-3.05
120์ผ
-0.09
5๋…„
+0.31

์œ„ํ—˜ ์š”์†Œ

์ตœ๋Œ€ ๋‚™ํญ
240์ผ
+66.04%
3๋…„
+95.85%
5๋…„
+99.19%
์ˆ˜์ต ๋Œ€๋น„ ๋‚™ํญ ๋น„์œจ
240์ผ
-0.20
3๋…„
-0.29
5๋…„
-0.20
์™œ๋„
240์ผ
+0.73
3๋…„
+23.13
5๋…„
+28.66

๋ณ€๋™์„ฑ

์‹คํ˜„ ๋ณ€๋™์„ฑ
240์ผ
+118.51%
5๋…„
+165.93%
ํ‘œ์ค€ํ™”๋œ ์ง„ํญ ๋ฒ”์œ„
240์ผ
+16.12%
5๋…„
+156.50%
ํ•˜๋ฐฉ ๋ฆฌ์Šคํฌ ์กฐ์ • ์ˆ˜์ต๋ฅ 
120์ผ
-18.72%
240์ผ
-18.72%
์ตœ๊ณ  ์ผ๊ฐ„ ์ƒ์Šน ๋ณ€๋™์„ฑ
60์ผ
+60.04%
์ตœ๊ณ  ์ผ๊ฐ„ ํ•˜๋ฝ ๋ณ€๋™์„ฑ
60์ผ
+59.12%

์œ ๋™์„ฑ

ํ‰๊ท  ํšŒ์ „์œจ
60์ผ
+13.40%
120์ผ
+7.57%
5๋…„
--
ํšŒ์ „์œจ ํŽธ์ฐจ
20์ผ
-96.82%
60์ผ
-82.06%
120์ผ
-89.87%

์œ ์‚ฌ ์ข…๋ชฉ
๎˜ฐ๎˜ฐ

์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ
๎™
Vivos Therapeutics Inc
Vivos Therapeutics Inc
VVOS
5.49 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.67 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Cencora Inc
Cencora Inc
COR
8.60 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
AxoGen Inc
AxoGen Inc
AXGN
8.58 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
TCMD
8.57 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc
ZBH
8.54 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
๋” ๋ณด๊ธฐ
tradingkey.logo
๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ์ด์šฉ ์•ฝ๊ด€์ด ์ ์šฉ๋ฉ๋‹ˆ๋‹ค. ์—ญ์‚ฌ์  ๋ฐ ํ˜„์žฌ ์ข…๊ฐ€ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๋ชจ๋“  ์‹œ์„ธ๋Š” ํ˜„์ง€ ๊ฑฐ๋ž˜์†Œ ์‹œ๊ฐ„ ๊ธฐ์ค€์ž…๋‹ˆ๋‹ค. ๋ฏธ๊ตญ ์ฃผ์‹ ์‹œ์„ธ์˜ ์‹ค์‹œ๊ฐ„ ๋งˆ์ง€๋ง‰ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Nasdaq์„ ํ†ตํ•ด ๋ณด๊ณ ๋œ ๊ฑฐ๋ž˜๋งŒ ๋ฐ˜์˜๋ฉ๋‹ˆ๋‹ค. ๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” ์ตœ์†Œ 15๋ถ„ ์ง€์—ฐ๋˜๊ฑฐ๋‚˜ ๊ฑฐ๋ž˜์†Œ ์š”๊ตฌ ์‚ฌํ•ญ์— ๋”ฐ๋ผ ๋‹ค๋ฅผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
* ์ฐธ๊ณ ์ž๋ฃŒ, ๋ถ„์„ ๋ฐ ํŠธ๋ ˆ์ด๋”ฉ ์ „๋žต์€ ์ œ3์ž ์ œ๊ณต์—…์ฒด์ธ Trading Central์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ๋ถ„์„๊ฐ€์˜ ๋…๋ฆฝ์ ์ธ ํ‰๊ฐ€์™€ ํŒ๋‹จ์— ๊ธฐ๋ฐ˜ํ•œ ์‹œ๊ฐ์œผ๋กœ, ํˆฌ์ž์ž์˜ ํˆฌ์ž ๋ชฉํ‘œ์™€ ์žฌ์ • ์ƒํ™ฉ์€ ๊ณ ๋ ค๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
KeyAI
๎™